DARE
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Dare Bioscience announces a new U.S. patent strengthening its DARE-HPV program as a potential first FDA-approved pharmacological treatment for HPV infectionSep 28, 2026
- Daré Bioscience receives NIH funding to advance DARE-HPV treatment programMay 26, 2026
- Daré Bioscience initiated a Phase 2 study of DARE-HPV for persistent high-risk HPV infectionMay 18, 2026
- Daré Bioscience announced return of rights to Ovaprene®; Phase 3 program ongoing with positive interim data and grant funding to position asset for value maximizationDec 1, 2025
- Daré Bioscience and Rosy Wellness launch patient-focused campaign supporting DARE to PLAY™ Sildenafil creamJul 29, 2025